- Our Products & Expertise
- About Baxter
- Corporate Responsibility
- Contact & Support
It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).
As we prepare for the next phase of our journey, we are committed to working on your behalf to build long-term shareholder value in pursuit of our mission.
Baxter delivered on a wide range of strategic objectives in 2014: We launched innovative healthcare technologies, advanced our new product development pipeline and expanded the global reach of our core portfolio. Our actions reflect Baxter's ongoing commitment to accelerating value for patients, investors, employees, and other stakeholders in line with our mission to save and sustain lives.View our latest Annual Report
|Data provided by Nasdaq. Minimum 15 minutes delayed.|
Analysts, portfolio managers, and current and prospective shareholders seeking additional investor information can contact Clare Trachtman at +1 (224) 948-3085.
Retail shareholder inquires may directed to Baxter Investor Relations at Global_CORP_Investor_Relations@baxter.com.Sign up for email alerts